scholarly article | Q13442814 |
P50 | author | Carlos Ros | Q88458880 |
P2093 | author name string | Christoph Kempf | |
Remo Leisi | |||
Chiarina Di Tommaso | |||
P2860 | cites work | Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. | Q54330531 |
Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy | Q69354191 | ||
Replication of the B19 parvovirus in human bone marrow cell cultures | Q69580453 | ||
Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro | Q70186121 | ||
Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits | Q71670097 | ||
Human parvovirus, the cause of erythema infectiosum (fifth disease)? | Q72554009 | ||
Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem | Q78032180 | ||
Human parvovirus B19. | Q24532891 | ||
Asymmetric binding of transferrin receptor to parvovirus capsids | Q24683829 | ||
Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force field | Q28261756 | ||
The Jpred 3 secondary structure prediction server | Q29547592 | ||
The family Parvoviridae | Q33578983 | ||
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins | Q33653001 | ||
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q. | Q33900233 | ||
Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments | Q33927991 | ||
Parvovirus-associated arthritis | Q33979933 | ||
Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review | Q33982832 | ||
Pathogenesis of human parvovirus B19 in rheumatic disease | Q34024904 | ||
Parvovirus-like particles in human sera | Q34214388 | ||
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface | Q34222176 | ||
Parvovirus B19. | Q34294811 | ||
Generation of a parvovirus B19 vaccine candidate | Q34355555 | ||
Clinical presentations of parvovirus B19 infection | Q34575717 | ||
The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization | Q34623255 | ||
Immune response to B19 parvovirus and an antibody defect in persistent viral infection | Q35815343 | ||
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions | Q36646671 | ||
Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism | Q37336824 | ||
Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process | Q38226745 | ||
Specific Targeting of Proerythroblasts and Erythroleukemic Cells by the VP1u Region of Parvovirus B19. | Q38846473 | ||
Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19. | Q39139995 | ||
Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1 | Q39305479 | ||
Characterization of the early steps of human parvovirus B19 infection | Q39327644 | ||
Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement | Q40358470 | ||
Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection | Q40389867 | ||
Visualization of the externalized VP2 N termini of infectious human parvovirus B19. | Q41337979 | ||
Parvovirus B19 VLP recognizes globoside in supported lipid bilayers. | Q42212619 | ||
The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability | Q43465663 | ||
Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry | Q44542238 | ||
Erythrocyte P antigen: cellular receptor for B19 parvovirus | Q45873217 | ||
His-tags as Zn(II) binding motifs in a protein-based fluorescent sensor | Q46575857 | ||
Site-specific cross-linking of proteins through tyrosine hexahistidine tags | Q46803340 | ||
Severe digital arterial occlusive disease and acute parvovirus B19 infection | Q48547968 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 61 | |
P577 | publication date | 2016-02-24 | |
P1433 | published in | Viruses | Q7935305 |
P1476 | title | The Receptor-Binding Domain in the VP1u Region of Parvovirus B19. | |
P478 | volume | 8 |
Q92026959 | Advances in the Development of Antiviral Strategies against Parvovirus B19 |
Q47727907 | Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome |
Q48244049 | Genetic analysis of three porcine bocaparvoviruses and identification of a natural recombinant breakpoint in NS1. |
Q92152922 | Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection |
Q38996997 | Human Parvoviruses |
Q89985874 | Inflammatory dilated cardiomyopathy : Etiology and clinical management |
Q55236939 | Recent Advances in Replication and Infection of Human Parvovirus B19. |
Q37378794 | The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells. |
Search more.